This study surveyed international nephrology society leaders, policy makers, and patient representatives to assess regional resources and ability to care for patients with kidney disease.
This Viewpoint argues that conventional definitions of medication reconciliation overlook the need to identify the correct list of medicines for patients, and discusses the challenges involved in defining who should be involved in defining and maintaining that list..
This study uses Medicare claims data to describe the use of annual wellness visits among Medicare beneficiaries in the United States from 2011 through 2014.
This study describes the number of H-1B visa physician applications and active care H-1B visa applications physicians by state and employer in 2016.
This Viewpoint defines mindsets—frames of mind that orient beliefs or expectations—discusses how they can influence patients’ perceptions about treatment and self-efficacy, and proposes ways physicians might shape patients’ mindsets during clinical encounters to enhance treatment effectiveness.
This Medical News article features an interview with 2 experts in field discussing the role of the microbiome in respiratory diseases.
This Viewpoint from the US Preventive Services Task Force (USPSTF) introduces their 2017 draft recommendation statement on screening for prostate cancer, explains how it differs from their 2012 recommendation, and invites public comment.
This Viewpoint discusses recommendations the US National Academies of Sciences and Medicine made in 2017 for the application and oversight of human genome editing in basic research, clinical disease, and germline cells.
This Viewpoint uses the example of the US FDA’s 2017 approval of desmopressin for treatment of nocturia to discuss the risks of approving a drug for symptoms rather than disease and the ways that the drug approval process is influenced by manufacturers and by overreliance on statistical vs clinical significance.
This Medical News article discusses the challenges physicians face in recommending medical marijuana.
This Viewpoint draws on 4 general behavioral economics principles to apply to health care insurance reform.